{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:48:55Z","timestamp":1782287335995,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,24]]},"DOI":"10.7759\/cureus.111404","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:22:56Z","timestamp":1782285776000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological Spectrum of Ovarian Tumors and Diagnostic Utility of Cancer Antigen 125 (CA-125): An Observational Study From Eastern India"],"prefix":"10.7759","author":[{"given":"Akanksha","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K","family":"Paswan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshu","family":"Jamaiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux S","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019, 69:280-304. 10.3322\/caac.21559","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00032","article-title":"Patterns of treatment and outcomes in epithelial ovarian cancer: a retrospective North Indian single-institution experience","volume":"8","author":"Meena RK","year":"2022","unstructured":"Meena RK, Syed NA, Sheikh ZA, et al.. Patterns of treatment and outcomes in epithelial ovarian cancer: a retrospective North Indian single-institution experience. JCO Glob Oncol. 2022, 8:e2200032. 10.1200\/GO.22.00032","journal-title":"JCO Glob Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11345","article-title":"Pathology and classification of ovarian tumors","volume":"97","author":"Chen VW","year":"2003","unstructured":"Chen VW, Ruiz B, Killeen JL, Cot\u00e9 TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer. 2003, 97:2631-42. 10.1002\/cncr.11345","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/jci110380","article-title":"Reactivity of a monoclonal antibody with human ovarian carcinoma","volume":"68","author":"Bast RC Jr","year":"1981","unstructured":"Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981, 68:1331-7. 10.1172\/jci110380","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M103554200","article-title":"Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16","volume":"276","author":"Yin BW","year":"2001","unstructured":"Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001, 276:27371-5. 10.1074\/jbc.M103554200","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast RC Jr","year":"1983","unstructured":"Bast RC Jr, Klug TL, St John E, et al.. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983, 309:883-7. 10.1056\/NEJM198310133091503","journal-title":"N Engl J Med"},{"key":"ref8","article-title":"CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records","volume":"27","author":"Funston G","year":"2021","unstructured":"Funston G, Mounce LT, Price S, Rous B, Crosbie EJ, Hamilton W, Walter FM. CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records. Br J Gen Pract. 2021, 27:465-72.","journal-title":"Br J Gen Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2002.6603","article-title":"The significance of serum CA 125 elevation in malignant and nonmalignant diseases","volume":"85","author":"Sj\u00f6vall K","year":"2002","unstructured":"Sj\u00f6vall K, Nilsson B, Einhorn N. The significance of serum CA 125 elevation in malignant and nonmalignant diseases. Gynecol Oncol. 2002, 85:175-8. 10.1006\/gyno.2002.6603","journal-title":"Gynecol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18231\/j.jdpo.2019.016","article-title":"Correlation of serum CA-125 with histopathological findings in ovarian tumors","volume":"4","author":"Prakash A","year":"2019","unstructured":"Prakash A, Pant H, Khandelwal R, Pandey S. Correlation of serum CA-125 with histopathological findings in ovarian tumors. IP J Diagn Pathol Oncol. 2019, 4:81-5. 10.18231\/j.jdpo.2019.016","journal-title":"IP J Diagn Pathol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123730","article-title":"CA125 and ovarian cancer: a comprehensive review","volume":"12","author":"Charkhchi P","year":"2020","unstructured":"Charkhchi P, Cybulski C, Gronwald J, Wong FO, Narod SA, Akbari MR. CA125 and ovarian cancer: a comprehensive review. Cancers (Basel). 2020, 12:3. 10.3390\/cancers12123730","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/JLP.JLP_117_18","article-title":"Distribution of various histopathological types of ovarian tumors: a study of 212 cases from a tertiary care center of Eastern Uttar Pradesh","volume":"11","author":"Gupta N","year":"2019","unstructured":"Gupta N, Yadav M, Gupta V, Chaudhary D, Patne SC. Distribution of various histopathological types of ovarian tumors: a study of 212 cases from a tertiary care center of Eastern Uttar Pradesh. J Lab Physicians. 2019, 11:75-81. 10.4103\/JLP.JLP_117_18","journal-title":"J Lab Physicians"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33092","article-title":"The histopathological patterns of ovarian neoplasms in different age groups: a retrospective study in a tertiary care center","volume":"14","author":"Farag NH","year":"2022","unstructured":"Farag NH, Alsaggaf ZH, Bamardouf NO, Khesfaty DM, Fatani MM, Alghamdi MK, Saharti SN. The histopathological patterns of ovarian neoplasms in different age groups: a retrospective study in a tertiary care center. Cureus. 2022, 14:e33092. 10.7759\/cureus.33092","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20174456","article-title":"Clinico-pathological profile of ovarian cysts in a tertiary care hospital","volume":"6","author":"Chanu SM","year":"2017","unstructured":"Chanu SM, Dey B, Raphael V, Panda S, Khonglah Y. Clinico-pathological profile of ovarian cysts in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2017, 6:4642-5. 10.18203\/2320-1770.ijrcog20174456","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijpo.2020.112","article-title":"Histopathological study of ovarian tumours in a tertiary healthcare centre of southern Rajasthan","volume":"7","author":"Sharma P","year":"2020","unstructured":"Sharma P, Rao PS, Mogra N, Talreja K. Histopathological study of ovarian tumours in a tertiary healthcare centre of southern Rajasthan. Indian J Pathol Oncol. 2020, 7:561-6. 10.18231\/j.ijpo.2020.112","journal-title":"Indian J Pathol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/8911.4709","article-title":"Clinico-histopathological analysis of neoplastic and non-neoplastic lesions of the ovary: a 3-year prospective study in dhule, north maharashtra, India","volume":"8","author":"Kanthikar SN","year":"2014","unstructured":"Kanthikar SN, Dravid NV, Deore PN, Nikumbh DB, Suryawanshi KH. Clinico-histopathological analysis of neoplastic and non-neoplastic lesions of the ovary: a 3-year prospective study in dhule, north maharashtra, India. J Clin Diagn Res. 2014, 8:FC04-7. 10.7860\/JCDR\/2014\/8911.4709","journal-title":"J Clin Diagn Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65342","article-title":"Evaluation of serum cancer antigen (CA)-125 levels as a biomarker for ovarian lesions: correlation with histopathological diagnosis and clinical outcomes","volume":"16","author":"Patil NJ","year":"2024","unstructured":"Patil NJ, Mane A, Hulwan AB, Asim Khan M, Umar H. Evaluation of serum cancer antigen (CA)-125 levels as a biomarker for ovarian lesions: correlation with histopathological diagnosis and clinical outcomes. Cureus. 2024, 16:e65342. 10.7759\/cureus.65342","journal-title":"Cureus"},{"key":"ref18","article-title":"Ovarian tumours: a study of 282 cases","volume":"100","author":"Pilli GS","year":"2002","unstructured":"Pilli GS, Suneeta KP, Dhaded AV, Yenni VV. Ovarian tumours: a study of 282 cases. J Indian Med Assoc. 2002, 100:420.","journal-title":"J Indian Med Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496769-clinicopathological-spectrum-of-ovarian-tumors-and-diagnostic-utility-of-cancer-antigen-125-ca-125-an-observational-study-from-eastern-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:22:57Z","timestamp":1782285777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496769-clinicopathological-spectrum-of-ovarian-tumors-and-diagnostic-utility-of-cancer-antigen-125-ca-125-an-observational-study-from-eastern-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.111404","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}